We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Stock Moves -1.26%: What You Should Know
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) ended the recent trading session at $372.80, demonstrating a -1.26% change from the preceding day's closing price. Elsewhere, the Dow saw a downswing of 0.36%, while the tech-heavy Nasdaq appreciated by 0.45%.
The stock of largest U.S. health insurer has fallen by 5.32% in the past month, lagging the Medical sector's loss of 3.65% and the S&P 500's gain of 1.27%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on October 13, 2026. The company is expected to report EPS of $4.12, up 41.1% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $111.38 billion, down 1.57% from the year-ago period.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $19.85 per share and a revenue of $446.78 billion, signifying shifts of +21.41% and -0.18%, respectively, from the last year.
Investors should also pay attention to any latest changes in analyst estimates for UnitedHealth Group. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.16% upward. Currently, UnitedHealth Group is carrying a Zacks Rank of #2 (Buy).
In terms of valuation, UnitedHealth Group is currently trading at a Forward P/E ratio of 19.02. This indicates a discount in contrast to its industry's Forward P/E of 23.21.
We can also see that UNH currently has a PEG ratio of 1.42. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The average PEG ratio for the Medical - HMOs industry stood at 1.42 at the close of the market yesterday.
The Medical - HMOs industry is part of the Medical sector. With its current Zacks Industry Rank of 32, this industry ranks in the top 14% of all industries, numbering over 250.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
View the Zacks #1 Rank List
Image: Bigstock
UnitedHealth Group (UNH) Stock Moves -1.26%: What You Should Know
UnitedHealth Group (UNH - Free Report) ended the recent trading session at $372.80, demonstrating a -1.26% change from the preceding day's closing price. Elsewhere, the Dow saw a downswing of 0.36%, while the tech-heavy Nasdaq appreciated by 0.45%.
The stock of largest U.S. health insurer has fallen by 5.32% in the past month, lagging the Medical sector's loss of 3.65% and the S&P 500's gain of 1.27%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on October 13, 2026. The company is expected to report EPS of $4.12, up 41.1% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $111.38 billion, down 1.57% from the year-ago period.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $19.85 per share and a revenue of $446.78 billion, signifying shifts of +21.41% and -0.18%, respectively, from the last year.
Investors should also pay attention to any latest changes in analyst estimates for UnitedHealth Group. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.16% upward. Currently, UnitedHealth Group is carrying a Zacks Rank of #2 (Buy).
In terms of valuation, UnitedHealth Group is currently trading at a Forward P/E ratio of 19.02. This indicates a discount in contrast to its industry's Forward P/E of 23.21.
We can also see that UNH currently has a PEG ratio of 1.42. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The average PEG ratio for the Medical - HMOs industry stood at 1.42 at the close of the market yesterday.
The Medical - HMOs industry is part of the Medical sector. With its current Zacks Industry Rank of 32, this industry ranks in the top 14% of all industries, numbering over 250.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.